Press Release: Pepric N.v : Novosibirsk Nanocentre invests in Pepric to engage in its international ambitions in the field of regenerative medicine and targeted particle therapies

Novosibirsk Nanocentre invested 1 million Euro in the Belgian company Pepric that developed particle analysis instruments for studies in the field of regenerative medicine and magnetic particle therapies. The advanced equipment allows to monitor the dynamics of injected therapeutic cells and targeted particle therapies within the animal body.read more